MPG
GH icon

My Portfolio Guide’s Guardant Health GH Stock Holding History

My Portfolio Guide’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.62K Buy
+50
New +$5.02K ﹤0.01% 137

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

My Portfolio Guide's GH Position: Q1 2026 in Review

My Portfolio Guide opened a new position in Guardant Health (GH) in Q1 2026: 50 shares worth $4.62K. The stake represents ﹤0.01% of the portfolio and ranks #137 among its holdings.

484 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • My Portfolio Guide held 50 shares of Guardant Health worth $4.62K as of Q1 2026.
  • Guardant Health was a new My Portfolio Guide position in Q1 2026.
  • Guardant Health made up ﹤0.01% of My Portfolio Guide's portfolio in Q1 2026, its #137 holding.
  • 484 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on My Portfolio Guide's 13F filing for Q1 2026, filed 6 May 2026.